Dinh, J. C., Boone, E. C., Staggs, V. S., Pearce, R. E., Wang, W. Y., Gaedigk, R., . . . Gaedigk, A. (2022). The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity. Clinical pharmacology and therapeutics, 111(3), 646. https://doi.org/10.1002/cpt.2469
Citace podle Chicago (17th ed.)Dinh, Jean C., Erin C. Boone, Vincent S. Staggs, Robin E. Pearce, Wendy Y. Wang, Roger Gaedigk, James Steven Leeder, a Andrea Gaedigk. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics 111, no. 3 (2022): 646. https://doi.org/10.1002/cpt.2469.
Citace podle MLA (9th ed.)Dinh, Jean C., et al. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics, vol. 111, no. 3, 2022, p. 646, https://doi.org/10.1002/cpt.2469.